Trans fatty acids from dairy foods do not affect risk of cardiometabolic diseases: systematic review and meta-analysis of evidence from randomized controlled trials and systematic review of prospective cohort studies

1. Comerford KB, Miller GD, Boileau AC, Masiello Schuette SN, Giddens JC, Brown KA. Global review of dairy recommendations in food-based dietary guidelines. Front Nutr 2021;8:671999. doi: 10.3389/fnut.2021.671999. 2. World Health Organization. An action package to eliminate industrially produced trans-fatty acids. WHO/NMH/NHD/18.4,2018. [cited 19 October 2021]. Available from: https://www.who.int/teams/nutrition-and-food-safety/replace-trans-fat 3. World Health Organization. Countdown to 2023: WHO report on global trans-fat elimination 2020. [cited 19 October 2021].Available from: https://www.who.int/publications/i/item/9789240010178 4. Zupanic N, Hribar M, Hristov H, Lavriša Ž, Kušar A, Gregoricˇ M, et al. Dietary intake of trans fatty acids in the Slovenian population. Nutrients 2021;13:207. doi: 10.3390/nu13010207. 5. Chandra A, Lyngbakken MN, Eide IA, Røsjø H, Vigen T, Ihle-Hansen H, et al. Plasma trans fatty acid concentrations, cardiovascular risk factors and lifestyle: results from the Akershus Cardiac Examination 1950 Study. Nutrients 2020;12:1419. doi:10.3390/nu12051419. 6. Niforou A, Magriplis E, Klinaki E, Niforou K, Naska A. On account of trans fatty acids and cardiovascular risk – there is still need to upgrade the knowledge and educate consumers. Nutr Metab Cardio Dis 2022;32:1811-8. doi:10.1016/j.numecd.2022.05.010. 7. Wanders AJ, Zock PL, Brouwer IA. Trans fat intake and its dietary sources in general populations worldwide: a systematic review. Nutrients 2017;9:840. doi: 10.3390/nu9080840. 8. Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009;63:S5–S21. doi:10.1038/sj.ejcn.1602973. 9. De Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015;351:h3978. doi: 10.1136/bmj.h3978. 10. Schwingshackl L, Zähringer J, Beyerbach J, Werner SA, Hesker H, Koletzko B, et al. Total dietary fat intake, fat quality, and health outcomes: a scoping review of systematic reviews of prospective studies. Ann Nutr Metab 2021;77:4-15. doi:10.1159/000515058. 11. Bendsen NT, Christensen R, Bartels EM, Astrup A. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr 2011;65:773–83. doi:10.1038/ejcn.2011.34. 12. Gayet-Boyer C, Tenenhaus-Aziza F, Prunet C, Marmonier C, Malpuech-Brugere C, Lamarche B, et al. Is there a linear relationship between the dose of ruminant trans fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomized clinical trials. Br J Nutr 2014;112:1914-22. doi:10.1017/S0007114514002578 13. Verneque BJF, Machado AM, de Abreu Silva L, Lopes ACS, Duarte CK. Ruminant and industrial trans-fatty acids consumption and cardiometabolic risk markers: a systematic review. Crit Rev Food Sci Nut 2022;62:2050-60. doi: 10.1080/10408398.2020.1836471. 14. Astrup A, Geiker NRW, Magkos F. Effects of full - fat and fermented dairy products on cardiometabolic disease: food is more than the sum of its parts. Adv Nutr 2019;10:924S–30S. doi: 10.1093/advances/nmz069. 15. Thorning TK, Bertram HC, Bonjour J-P, de Groot L, Dupont D, Feeney E, et al. Whole dairy matrix or single nutrients in assessment of health effects: current evidence and knowledge gaps. Am J Clin Nutr 2017;105:1033–45. doi: 10.3945/ajcn.116.151548. 16. Shingfield KJ, Bonnet M, Scollan ND. Recent developments in altering the fatty acid composition of ruminant-derived foods. Animal 2013;7:132-62. doi: 10.1017/S1751731112001681 17. Hirahatake KM, Astrup A, Hill JO, Slavin JL, Allison DB, Maki KC. Potential cardiometabolic health benefits of full-fat dairy: the evidence base. Adv Nutr 2020;11:533–47. doi: 10.1093/advances/nmz132. 18. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 Statement. Syst Rev 2015;4:1. doi: 10.1186/2046-4053-4-1. 19. Tholstrup T, Sandström B, Hermansen JE, Hølmer G. Effect of modified dairy fat on postprandial and fasting plasma lipids and lipoproteins in healthy young men. Lipids 1998;33:11-21. doi: 10.1007/s11745-998-0175-0. 20. Gagliostro GA, Antonacci LE, Pérez CD, Rossetti L, Tassone M, Frossasco V, et al. Increasing conjugated linoleic acid content in milk and cheese after supplementing a blend of crude soybean oil sediment combined with fish oil to grazing dairy cows. Open J Anim Sci 2020;10:468-92. doi.org/10.4236/ojas.2020.103029. 21. Tsiplakou E, Zervas G. Changes in milk and plasma fatty acid profile in response to fish and soybean oil supplementation in dairy sheep. J Dairy Res 2013;80:205-13. doi: 10.1017/S0022029913000137. 22. Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions, version 6.3 Cochrane, 2022. [cited 11 May 2022]. Available from: www.cochrane.org/handbook. 23. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 19 October 2021]. Available from: https://www.ohri.ca//programs/clinical_epidemiology/oxford.asp. 24. Desroches S, Chouinard PY, Galibois I, Corneau L, Delisle J, Lamarche B, et al. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr 2005;82:309–19. doi: 10.1093/ajcn.82.2.309. 25. Lacroix E, Charest A, Cyr A, Baril-Gravel L, Lebeuf Y, Paquin P, et al. Randomized controlled study of the effect of a butter naturally enriched in trans fatty acids on blood lipids in healthy women. Am J Clin Nutr 2012;95:318-25. doi:10.3945/ajcn.111.023408. 26. Malpuech-Brugère C, Mouriot J, Boue-Vaysse C, Combe N, Peyraud JL, LeRuyet P, et al. Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women. Eur J Clin Nutr 2010;64:752-9. doi: 10.1038/ejcn.2010.73. 27. Motard-Bélanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, et al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008;87:593-9. doi:10.1093/ajcn/87.3.593. 28. Pintus S, Murru E, Carta G, Cordeddu L, Batetta B, Accossu S, et al. Sheep cheese naturally enriched in α-linolenic, conjugated linoleic and vaccenic acids improves the lipid profile and reduces anandamide in the plasma of hypercholesterolaemic subjects. Br J Nutr 2013;109:1453-62. doi: 10.1017/S0007114512003224. 29. Santurino C, López-Plaza B, Fontecha J, Calvo MV, Bermejo LM, Gómez-Andrés D, et al. Consumption of goat cheese naturally rich in omega-3 and conjugated linoleic acid improves the cardiovascular and inflammatory biomarkers of overweight and obese subjects: a randomized controlled trial. Nutrients 2020;12:1315. doi:10.3390/nu12051315. 30. Santurino C, Calvo MV, Gómez-Candela CV, Fontecha J. Characterization of naturally goat cheese enriched in conjugated linoleic acid and omega-3 fatty acids for human clinical trial in overweight and obese subjects. Pharma Nutrition 2017;5:8-17. doi.org/10.1016/j.phanu.2016.12.001. 31. Sofi F, Buccioni A, Cesari F, Gori AM, Minieri S, Mannini L, et al. Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: a dietary intervention study. Nutr Metab Cardiovasc Dis 2010;20:117-24. doi: 10.1016/j.numecd.2009.03.004. 32. Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 2006;8:237-43. doi: 10.1093/ajcn/83.2.237. 33. Tricon S, Burdge GC, Jones EL, Russell JJ, El-Khazen S, Moretti E, et al. Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am J Clin Nutr 2006;83:744-53. doi:10.1093/ajcn/83.4.744. 34. Venkatramanan S, Joseph SV, Chouinard PY, Jacques H, Farnworth ER, Jones PJ. Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals. J Am Coll Nutr 2010;29:152-9. doi: 10.1080/07315724.2010.10719829. 35. Valenzuela C, Bakera, EJ, Milesa, EA, Calder PC. Eighteen‑carbon trans fatty acids and inflammation in the context of atherosclerosis. Prog Lipid Res 2019;76:101009. https://doi.org/10.1016/j.plipres.2019.101009. 36. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, et al. Trans palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013;97:854-61.doi: 10.3945/ajcn.112.045468. 37. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 2010;153:790-9. doi: 10.1059/0003-4819-153-12-201012210-00005. 38. Borgeraas H, Hertel JK, Seifer R, Berge RK, Bohov P, Ueland PM, et al. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study. Lipids Health Dis 2016;15:38. doi 10.1186/s12944-016-0204-9. 39. de Oliveira Otto MC, Lemaitre RN, Song X, King IB, Siscovick DS, Mozaffarian D. Serial measures of circulating biomarkers of dairy fat and total and cause-specific mortality in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2018;108:476–84. doi: 10.1093/ajcn/nqy117. 40. de Oliveira Otto MC, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS, et al. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2013;2:e000092. doi: 10.1161/JAHA.113.000092. 41. Kleber ME, Delgado GE, Lorkowski S, Marz W, von Schacky C. Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study. Eur Heart J 2016;37:1072–8.doi:10.1093/eurheartj/ehv446. 42. Li H, Zhang Q, Song J, Wang A, Zou Y, Ding L, et al. Plasma trans-fatty acids levels and mortality: a cohort study based on 1999–2000 National Health and Nutrition Examination Survey (NHANES). Lipids Health Dis 2017;16:176. doi:10.1186/s12944-017-0567-6. 43. Santaren ID, Watkins SM, Liese AD, Wagenknecht LE, Rewers MJ, Haffner SM, et al. Serum pentadecanoic acid (15:0), a short term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. Am J Clin Nutr 2014;100:1532-40. doi: 10.3945/ajcn.114.092544. 44. Santaren ID. Investigating serum dairy fatty acid biomarkers and their association with type 2 diabetes and its underlying disorders [thesis]. University of Toronto; 2014. 45. Takkunen MJ, Schwab US, de Mello VDF, Eriksson JG, Lindström J, Tuomilehto J, et al. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr 2016;55:967-79. doi 10.1007/s00394-015-0911-4. 46. Wang Q, Imamura F, Ma W, Wang M, Lemaitre RN, King IB, et al. Circulating and dietary trans-fatty acids and incident type-2 diabetes mellitus in older adults: the cardiovascular health study. Diabetes Care 2015;38:1099–107. doi: 10.2337/dc14-2101. 47. Yakoob MY, Shi P, Hu FB, Willett WC, Rexrode KM, Campos H, et al. Circulating biomarkers of dairy fat and incident type 2 diabetes in two U.S. prospective cohort studies. Circulation 2016;133:1645–54. doi: 10.1161/CIRCULATIONAHA.115.0184102014;129. 48. Huang NK, Bůžková P, Matthan NR, Djoussé L, Hirsch CH, Kizer, JR, et al. Associations of serum non-esterified fatty acids with coronary heart disease mortality and nonfatal myocardial infarction: the CHS (Cardiovascular Health Study) cohort. J Am Heart Assoc 2021;10:e019135. doi: 10.1161/JAHA.120.019135. 49. Huang NK, Biggs ML, Matthan NR, Djoussé L, Longstreth, Jr. WT, Mukamal KJ, et al. Serum nonesterified fatty acids and incident stroke: The CHS. J Am Heart Assoc 2021;10:e022725. doi: 10.1161/JAHA.121.022725. 50. Chen G, Yan Li, Zeng F, Deng G, Liang J, Wang J, et al. Biomarkers of fatty acids and risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr 2021;61:2705-18. doi:10.1080/10408398.2020.1784839. 51. Liang J, Zhou Q, Amakye WK, Su Y, Zhang Z. Biomarkers of dairy fat intake and risk of cardiovascular disease: A systematic review and meta-analysis of prospective studies. Crit Rev Food Sci Nutr 2018;58:1122-30. doi:10.1080/10408398.2016.1242114. 52. Brouwer IA, Wanders AJ, Katan MB. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans – a quantitative review. PLoS ONE 2010;5:e9434. doi: 10.1371/journal.pone.0009434. 53. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146–55. doi: 10.1093/ajcn/77.5.1146. 54. Destaillats F, Wolff R.L, Precht D, Molkentin J. Study of individual trans- and cis-16∶1 isomers in cow, goat, and ewe cheese fats by gas-liquid chromatography with emphasis on the trans-Δ3 isomer. Lipids 2000;35:1027–32. doi: 10.1007/s11745-000-0614-y.